Immunic Q1 2026 Earnings EPS Miss but Stock Surges 6 as Clinical Progress May Lift Sentiment LUXE Q1 2026 Earnings EPS Miss Weighs on Sentiment as Revenue Data Remains Withheld Jasper Therapeutics JSPR Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Higher LFCR Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Reaction FOSL Q1 2026 Earnings BetterThanExpected Loss Fails to Rally Investors Blackbaud Inc BLKB Q1 2026 Earnings Modest EPS Beat Points to Steady Execution in Cloud Transition